Showing results (41-50 of 299) with videos related to
Sort By:
Pageof 30
Biochimica Et Biophysica Acta|June 6, 2000
The IF(1) inhibitor protein of the mitochondrial F(1)F(0)-ATPaseD W Green, G J GroverThe Journal of Surgical Research|December 1, 1984
Role of the liver in host defense to pneumococcus following splenectomyG J Grover, D J LoegeringCanadian Journal of Physiology and Pharmacology|September 1, 1987
T4-induced cardiac hypertrophy and the perfused and total microvasculature of the heartH R Weiss, G J GroverCirculatory Shock|January 1, 1987
Coronary adjustments to graded hypotension in rabbitsG J Grover, H R WeissCirculation Research|March 1, 1989
Role of thromboxane A2 in the control of myocardial O2 supply/consumption balance and severity of ischemia during pacing-induced ischemiaG J Grover, C S ParhamCardiovascular Drug Reviews|August 15, 2002
Pharmacologic profile of the selective mitochondrial-K(ATP) opener BMS-191095 for treatment of acute myocardial ischemiaGary J Grover, Karnail S AtwalThe Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
Thromboxane A2 antagonist and diltiazem-induced enhancement of contractile function: the effect of timing of treatmentG J Grover, I E FulmorJournal of Cardiovascular Pharmacology|November 1, 1995
Protective effect of K(ATP) openers in ischemic rat hearts treated with a potassium cardioplegic solutionG J Grover, P G SlephThe Journal of Pharmacology and Experimental Therapeutics|February 1, 1989
Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserveG J Grover, W A SchumacherBasic Research in Cardiology|January 1, 1989
The effect of the thromboxane A2 receptor antagonist SQ 29,548 on the severity of pacing-induced ischemiaG J Grover, W A SchumacherPageof 30